GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipca Laboratories Ltd (BOM:524494) » Definitions » Market Cap

Ipca Laboratories (BOM:524494) Market Cap : ₹334,725 Mil (As of May. 29, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Ipca Laboratories Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Ipca Laboratories's share price for the quarter that ended in Dec. 2023 was ₹1113.35. Ipca Laboratories's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 254 Mil. Therefore, Ipca Laboratories's market cap for the quarter that ended in Dec. 2023 was ₹282,461 Mil.

Ipca Laboratories's quarterly market cap increased from Jun. 2023 (₹188,299 Mil) to Sep. 2023 (₹236,706 Mil) and increased from Sep. 2023 (₹236,706 Mil) to Dec. 2023 (₹282,461 Mil).

Ipca Laboratories's annual market cap increased from Mar. 2021 (₹241,374 Mil) to Mar. 2022 (₹269,218 Mil) but then declined from Mar. 2022 (₹269,218 Mil) to Mar. 2023 (₹205,576 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Ipca Laboratories's Enterprise Value for Today is ₹344,227 Mil.


Ipca Laboratories Market Cap Historical Data

The historical data trend for Ipca Laboratories's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipca Laboratories Market Cap Chart

Ipca Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 124,153.48 175,389.21 241,373.99 269,218.00 205,576.35

Ipca Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 213,897.84 205,576.35 188,299.11 236,705.83 282,461.35

Competitive Comparison of Ipca Laboratories's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Ipca Laboratories's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ipca Laboratories's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ipca Laboratories's Market Cap distribution charts can be found below:

* The bar in red indicates where Ipca Laboratories's Market Cap falls into.



Ipca Laboratories Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Ipca Laboratories's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as

Market Cap (A: Mar. 2023 )=Share Price (A: Mar. 2023 )*Shares Outstanding (EOP) (A: Mar. 2023 )
=₹810.3*253.704
=₹205,576

Ipca Laboratories's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=₹1113.35*253.704
=₹282,461

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ipca Laboratories  (BOM:524494) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Ipca Laboratories Market Cap Related Terms

Thank you for viewing the detailed overview of Ipca Laboratories's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Ipca Laboratories (BOM:524494) Business Description

Traded in Other Exchanges
Address
125, Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067
Ipca Laboratories Ltd is a specialty and generic drug manufacturing company. The company's principal activity is Development, Manufacturing and Marketing of Pharmaceuticals Products. The company operates multiple subsidiaries with revenue generation split roughly between India and the rest of the world. Ipca's products are exported to more than 100 countries across the globe. Ipca has only one reportable primary business segment, pharmaceuticals.

Ipca Laboratories (BOM:524494) Headlines

No Headlines